- Home
- Publications
- Publication Search
- Publication Details
Title
Updates on thrombotic events associated with multiple myeloma
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 12, Issue 5, Pages 355-365
Publisher
Informa UK Limited
Online
2019-04-08
DOI
10.1080/17474086.2019.1604214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
- (2019) Corinne Frere et al. Cancers
- Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
- (2019) Robert Frank Cornell et al. Frontiers in Oncology
- Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants
- (2019) Maria Cristina Vedovati et al. THROMBOSIS RESEARCH
- Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens
- (2018) Neill P. F. Storrar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences
- (2018) Audrey Bellesoeur et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions
- (2018) Hanno Riess et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prediction of venous thromboembolism (VTE) in multiple myeloma (MM): Myeloma clot score (MCS).
- (2018) Kristen Marie Sanfilippo et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
- (2018) Martin W. Schoen et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
- (2018) Dawn Swan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
- (2018) Despina Fotiou et al. Blood Cancer Journal
- Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation
- (2018) Hailey A. Baker et al. Cancer Medicine
- Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial
- (2017) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of direct oral anticoagulants in patients on immunomodulatory agents
- (2017) L. Man et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
- (2017) Grigoris T. Gerotziafas et al. ONCOLOGIST
- Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia
- (2016) Nabin Khanal et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review
- (2016) Ming Sheng Lim et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2016) Dominique Farge et al. LANCET ONCOLOGY
- Thromboprophylaxis in multiple myeloma patients treated with lenalidomide – A systematic review
- (2016) Fatimah Al-Ani et al. THROMBOSIS RESEARCH
- A review of the venous thrombotic issues associated with multiple myeloma
- (2016) Despina Fotiou et al. Expert Review of Hematology
- Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
- (2015) Heyu Huang et al. BLOOD COAGULATION & FIBRINOLYSIS
- Induction therapy alters plasma fibrin clot properties in multiple myeloma patients
- (2015) Anetta Undas et al. BLOOD COAGULATION & FIBRINOLYSIS
- Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma
- (2015) A Keith Stewart Future Oncology
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2015) Z. Hanaizi et al. ONCOLOGIST
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
- (2014) P. G. Richardson et al. BLOOD
- Venous Thromboembolism in Patients With Myeloma
- (2014) Maeve P. Crowley et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
- (2014) M A Dimopoulos et al. LEUKEMIA
- Venous Thromboembolism in Multiple Myeloma
- (2014) Tommaso Za et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- (2014) M A Dimopoulos et al. Blood Cancer Journal
- Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
- (2013) Tina Bagratuni et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myelome 2009-02
- (2013) X. Leleu et al. BLOOD
- Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients
- (2013) J. E. Geddings et al. BLOOD
- Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin
- (2013) Wan Z. Abdullah et al. BLOOD COAGULATION & FIBRINOLYSIS
- Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma
- (2013) Guillemette Fouquet et al. CANCER
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs
- (2013) Philippe Rodon et al. THROMBOSIS AND HAEMOSTASIS
- Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study
- (2012) Rachel Rosovsky et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thrombosis is associated with inferior survival in multiple myeloma
- (2012) S. Y. Kristinsson et al. HAEMATOLOGICA
- Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
- (2012) M. A. Dimopoulos et al. HAEMATOLOGICA
- Thrombosis in multiple myeloma (MM)
- (2012) Cesarman-Maus Hematology
- A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
- (2012) Melina Verso et al. Internal and Emergency Medicine
- Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma
- (2012) Marta Robak et al. MEDICAL ONCOLOGY
- Risk and management of thrombosis in multiple myeloma
- (2012) Frank W.G. Leebeek et al. THROMBOSIS RESEARCH
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Activated protein C resistance as measured by residual factor V after Russellʼs Viper Venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls
- (2011) Maurizio Zangari et al. BLOOD COAGULATION & FIBRINOLYSIS
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
- (2011) Cihan Ay et al. JOURNAL OF CLINICAL ONCOLOGY
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
- (2011) Sandro Barni et al. Journal of Translational Medicine
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- (2011) M A Dimopoulos et al. LEUKEMIA
- Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
- (2011) Elena Zamagni et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Thrombosis in Multiple Myeloma
- (2011) S. Y. Kristinsson Hematology-American Society of Hematology Education Program
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Multiple myeloma: biology of the disease
- (2010) Anuj Mahindra et al. BLOOD REVIEWS
- Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin
- (2010) Michela Cini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
- (2010) J. J. A. Auwerda et al. THROMBOSIS AND HAEMOSTASIS
- Venous Thromboembolism in the Hematologic Malignancies
- (2009) Anna Falanga et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- (2008) C. Ay et al. BLOOD
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- (2008) S. Y. Kristinsson et al. BLOOD
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started